Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers

NCT00619060 ↗

Phase 1 Completed 22 enrolled University of Arizona National Cancer Institute (NCI) · collab

RandomizedParallel-groupQuadruple-blindPrevention

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of topical myristyl nicotinate cream may stop skin cancer from forming. PURPOSE: This randomized phase I trial is studying the side effects and best way to give topical myristyl nicotinate cream on the skin of healthy volunteers.

Timeline

Start: 2007-08
Primary completion: 2008-07
Completion: 2008-07

Outcome

Results reported · no primary-endpoint met/missed verdict (typical of a dose-finding / safety study)

registry NUMBER Myristyl Nicotinate Cream: 8 participants NCT00619060 ↗

registry NUMBER Topical Placebo Cream: 2 participants NCT00619060 ↗

registry Myristyl Nicotinate Cream vs Topical Placebo Cream; p = 0.01; Binomial NCT00619060 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Myristyl Nicotinate	Unknown	—	Topical

Indications

No indication recorded.